Publisher: Yahoo! Finance

The University of Tennessee Health Science Center (UTHSC), oncology drug discovery research partner to Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for SARS-CoV-2 and other viral ARDS-related diseases, has secured two additional grants to develop oncology therapeutics for indications of… Read More

Le Bonheur Children’s Hospital, in partnership with the Ryan Seacrest Foundation, opened a new state-of-the-art 1,275 square-foot broadcast media center called Seacrest Studio on Wednesday. As the primary pediatric teaching affiliate for the University of Tennessee Health Science Center, Le Bonheur trains more than 350 pediatricians and specialists each year.

The use of chatbots and natural language processing technology, such as ChatGPT, has the potential to change the future of medical writing —with some caveats— says Som Biswas, MD, a Radiology fellow at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center, in an article published in Radiology. The published article was written entirely by ChatGPT… Read More

Provectus (OTCQB: PVCT) today announced that preclinical research on the Company’s pharmaceutical-grade rose bengal sodium drug substance against colistin-resistant gram-negative (G-) bacteria was published in The Journal of Antibiotics, a medical periodical by Nature Portfolio for the Japan Antibiotics Research Association. Colistin is used as a last-resort treatment for infections when other drugs fail. The World… Read More

Kevin Foley, MD, Chairman of Semmes-Murphey Neurologic and Spine Institute and professor of neurosurgery, orthopedic surgery and biomedical engineering at the University of Tennessee Health Science Center stated, “The Inspire porous PEEK technology checks all of the boxes for an ideal interbody implant: fully interconnected porosity, modulus of elasticity equivalent to cancellous bone, strong biomechanical… Read More

Cellworks Group Inc., a leader in Precision Drug Development and Personalized Therapy Biosimulation, today announced results from a study that examined how Differentiation Scoring (DS) derived from key myeloid biomarkers in individual Myelodysplastic Syndrome (MDS) patients using the Cellworks Platform and Computational Biology Model (CBM) can predict response to Hypomethylating Agents (HMA). “MDS patients typically… Read More

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces Daxor’s BVA-100 diagnostic will be featured in a MedAxiom Academy webinar – Best Practices for Using Blood Volume Analysis to Reduce Heart Failure LOS, Readmissions, Mortality and Costs on November 17, 2022, at 1pm ET. The panel of distinguished speakers includes… Read More

Medtronic Stroke is a leading cause of death and disability around the world, but only a fraction of people who suffer a stroke get treatment in time. Medtronic is taking bold new steps to change that by launching the Medtronic Neurovascular Co-Lab™, an innovation process and platform for new ideas in the treatment of stroke care.… Read More